In 2023-24, RSV vaccines were 79% effective against virus-related blood clots in older adults, CDC estimates
Respiratory syncytial virus (RSV) vaccines have been an estimated 79% efficient towards harmful virus-related blood clots amongst Medicare recipients within ...


